As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.
India's largest drugmaker, Ranbaxy, will have an exclusive six-month marketing opportunity to sell a generic version of Japanese drugmaker Eisai's drug for Alzheimer's in the US.
'Supplies should start moving to the Serum Institute without any impediments.'
Should Indian cigarette packs also have photos like these to dissuade smokers? Tell us now!
The Maharashtra Food and Drug Authority has issued notice to Johnson and Johnson, as six products including baby shampoo and baby oil were found to have carcinogenic substances.
This time food regulators found excess presence of ash content in Maggi
India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.
The US Food and Drug Administration has issued two warning letters to Ranbaxy claiming procedural violations at its plants in Dewas and Paonta Sahib in India. Giuliani, a high-profile Republican leader and former US attorney in Manhattan, would provide advice and review compliance issues. Ranbaxy has been accused of selling generic drugs which did not meet FDA standards.
The Maharashtra Food and Drug Administration seized gutkha worth over Rs 7 lakh from various parts of the state over the last two days in an effort to enforce the ban on gutkha sales.
The Maharashtra Food and Drug Administration has issued a show cause notice to a Pune-based diversified group for putting 'objectionable' label in its bottled mineral water and seized water bottles worth Rs 245,000 from Aurangabad.
Tyson said he wants to spread word of the benefits of psilocybin as widely as possible, which is why he has partnered with Wesana.
There are just 1,500 drug inspectors responsible for more than 10,000 factories in India
The labs have been asked to submit their report within six weeks.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
Dr Reddy's gets warning from US health regulator
Meticulous hand washing is your best bet to get rid of the grime that clings to the hand, that might harbour nasty pathogens, including the coronavirus.
The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.
US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.
'As a donor, you may think you are saving one life. But you touch the lives of the entire family and community associated with the person. And it only cost you a few hours of your life.'
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
The news comes as the United States approaches 300,000 deaths from COVID-19.
Speaking at the Conservative Political Action Committee in Orlando, Florida on Sunday, the 74-year-old leader, who left the White House on January 20, stopped short of announcing to run for the president in 2024, although he gave enough indications that he is moving in that direction.
Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
Data also show that several other leading domestic pharma companies have recalled their products from the US
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
'The government had a vaccine from January.' 'The government should have given the vaccine to all population above the age of 45, right from the start.' 'Each state has its own problems, but as far as vaccine coverage in India is concerned, there have been mistakes.'
the Maharashtra Food and Drug Administration on Saturday issued directives to various departments to cancel the licences of gutkha manufacturers, wholesalers and retailers in the state after finding magnesium carbonate in gutkha.
'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'
The US market for the drug is pegged at $1 billion. Cipla has been selling the product in the European market. It had won a similar case in the UK against GSK a couple of years ago.
Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.
These vaccines have not yet been approved by the World Health Organization
The move comes after a FDA notice to gutkha manufacturers to mention the contents of their product on the cover.
The move follows an FDA inspection of a Ranbaxy facility which identified significant violations of sound manufacturing practices.
